I-123 Biomarker Committee: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
mNo edit summary |
||
| Line 1: | Line 1: | ||
{{TOCright}} | {{TOCright}} | ||
:Co-chairs: John Dickson, PhD; John Seibyl, MD | :Co-chairs: John Dickson, PhD; John Seibyl, MD | ||
: | :RSNA Staff Support: Julie Lisiecki | ||
* [http://tinyurl.com/QIBA-SPECT-I-123-Roster Roster] | * [http://tinyurl.com/QIBA-SPECT-I-123-Roster Roster] | ||
Revision as of 16:52, 22 May 2019
- Co-chairs: John Dickson, PhD; John Seibyl, MD
- RSNA Staff Support: Julie Lisiecki
Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases
Recent Meetings/Call Summaries
Profile Development
Reference Materials
- QIBA SPECT I-123 Biomarker Committee Presentation (11.16.2018) John Seibyl, MD